Related Experiment Video
Updated: Jun 11, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Abstract:
This article is based on the experimental results obtained on the inhibition of tumor promotion by the application of certain compounds. Retinoids are well investigated anti-tumor promoters which inhibit the tumor promotion of 12-O-tetradecanoylphorbol-13-acetate applied to mouse skin. We screened a number of possible anti-tumor promoters by short-term tests. The compounds which gave positive results in the tests were subjected to a long-term iu vivo two-stage carcinogenesis experiment with DMBA plus teleocidin on mouse skin. We found that a calmodulin antagonist, quercetin, anti-inflammatory agents and tannic acids were able to act as new anti-tumor promoters. One of the tannic acids tested is (-)-epigallocatechin gallate, a tannic acid contained in tea. However, the short-term tests have still not been able to detect the anti-tumor promoter satisfactorily. Recently, we found that sarcophytol A inhibits tumor promotion in mouse skin with an equimolar ratio of teleocidin. A study on the action of sarcophytol A is now under investigation. In addition, the primary and the secondary chemoprevention of cancer were also briefly mentioned.
Insights
Researchers identified new anti-tumor promoters, including quercetin, anti-inflammatory agents, and tannic acids like epigallocatechin gallate from tea. Sarcophytol A also shows promise in inhibiting tumor promotion in mouse skin models.
Area of Science:
- Oncology
- Pharmacology
Context:
- Tumor promotion is a critical stage in carcinogenesis, often targeted by chemopreventive agents.
- Retinoids are established anti-tumor promoters, inhibiting 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin tumor promotion in mice.
- Short-term screening tests are utilized to identify potential anti-tumor promoter compounds.
Purpose:
- To screen and identify novel compounds that inhibit tumor promotion.
- To validate the efficacy of identified compounds using long-term in vivo carcinogenesis experiments.
- To investigate the anti-tumor promotion activity of sarcophytol A.
Summary:
- Experimental screening identified quercetin (a calmodulin antagonist), anti-inflammatory agents, and tannic acids as novel anti-tumor promoters.
- (-)-Epigallocatechin gallate, a component of tea, demonstrated anti-tumor promotion activity.
- Sarcophytol A was found to inhibit tumor promotion in mouse skin, with its mechanism currently under investigation.
- The study also briefly touches upon primary and secondary cancer chemoprevention strategies.
Impact:
- Identifies new classes of compounds with potential for cancer chemoprevention.
- Highlights the anti-tumor promotion potential of natural compounds like epigallocatechin gallate and sarcophytol A.
- Suggests the need for improved short-term screening methods for anti-tumor promoters.
More Related Videos
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
05:36Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron
Published on: February 23, 2024
Related Concept Videos
Cancer
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Prevention
Some...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...